
Research peptides
Semax
Semax is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) developed in Russia, combining the ACTH(4-7) fragment with a Pro-Gly-Pro tail; it is often described as an ACTH(4-10) analog.
- Container
- Glass vial, crimp seal, flip-top cap
- Storage
- -20 °C, desiccated
- Paperwork
- Lot certificate (HPLC + mass spec) shown before you pay
Lot certificates
You’ll see American Peptides on the lab’s copy. They’re our supplier.
- 10 mg, lot SEMX10-0803: 99.82% purity (RP-HPLC), 10.50 mg measured, identity confirmed by mass spec. Issued 2026-08-28 by Bioviridian Inc.. Verify certificate COA7586
Our vials are filled from lots made by our supplier, American Peptides, and tested by Bioviridian Inc.The laboratory’s original certificate lists American Peptides as the vendor. Look up the code at bioviridians.com to check it.
What researchers study it for
- Cerebral ischemia in rat models
- BDNF and TrkB expression
- Learning and memory in rodents
- Alzheimer's-type animal models
How it is thought to work
In rats, Semax has been associated with increased hippocampal BDNF and TrkB expression and with neurotrophin gene transcription after experimental ischemia. It lacks hormonal ACTH activity. Its receptor target is not established; in one cell study it did not activate the melanocortin-4 receptor but blunted alpha-MSH signaling.
Where the research stands
Registered in Russia; not FDA-approved. Semax is on Russia's government list of vital and essential drugs, but it is not FDA-approved and much of its clinical evidence comes from Russian studies lacking independent validation.
Sources
- Dolotov OV, Karpenko EA, Inozemtseva LS, Seredenina TS, et al. (2006). Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus.. Brain Res.
- Dmitrieva VG, Povarova OV, Skvortsova VI, Limborska SA, Myasoedov NF, Dergunova LV (2010). Semax and Pro-Gly-Pro activate the transcription of neurotrophins and their receptor genes after cerebral ischemia.. Cell Mol Neurobiol.
- Filippenkov IB, Stavchansky VV, Denisova AE, Yuzhakov VV, et al. (2020). Novel Insights into the Protective Properties of ACTH(4-7)PGP (Semax) Peptide at the Transcriptome Level Following Cerebral Ischaemia-Reperfusion in Rats.. Genes (Basel).
- Radchenko AI, Kuzubova EV, Apostol AA, Mitkevich VA, et al. (2025). The Potential of the Peptide Drug Semax and Its Derivative for Correcting Pathological Impairments in the Animal Model of Alzheimer's Disease.. Acta Naturae.
- Mavrych V, Shypilova I, Bolgova O (2026). Therapeutic peptides in gerontology: mechanisms and applications for healthy aging.. Front Aging.
Read more
For laboratory research use only. Not a drug, food, supplement or cosmetic; not for human or veterinary use. Nothing on this page is medical advice or a usage guide.
